Decline in financial settlements with U.S. Big Pharma -report

WASHINGTON, March 31 (Reuters) - The amount of money big

U.S. pharmaceutical manufacturers have paid to settle charges

for violating federal health care laws has declined sharply in

recent years,...

Read more